vs

Side-by-side financial comparison of General Enterprise Ventures, Inc. (CITR) and Vir Biotechnology, Inc. (VIR). Click either name above to swap in a different company.

General Enterprise Ventures, Inc. is the larger business by last-quarter revenue ($288.2K vs $240.0K, roughly 1.2× Vir Biotechnology, Inc.). General Enterprise Ventures, Inc. runs the higher net margin — -2751.2% vs -67975.4%, a 65224.2% gap on every dollar of revenue. On growth, General Enterprise Ventures, Inc. posted the faster year-over-year revenue change (169.3% vs -89.9%). General Enterprise Ventures, Inc. produced more free cash flow last quarter ($-1.5M vs $-167.9M). Over the past eight quarters, General Enterprise Ventures, Inc.'s revenue compounded faster (218.8% CAGR vs -88.0%).

The Hewlett Packard Enterprise Company (HPE) is an American multinational information technology company based in Spring, Texas. It is a business-focused organization which works in servers, storage, networking, containerization software and consulting and support. HPE was ranked No. 107 in the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Vir Biotechnology, Inc. is a clinical-stage immunology company focused on developing innovative therapies and vaccines to address serious infectious diseases including COVID-19, hepatitis B, HIV, and influenza. It operates primarily in the global biopharmaceutical market, collaborating with leading industry partners to advance its pipeline of targeted immune-based solutions for patient populations worldwide.

CITR vs VIR — Head-to-Head

Bigger by revenue
CITR
CITR
1.2× larger
CITR
$288.2K
$240.0K
VIR
Growing faster (revenue YoY)
CITR
CITR
+259.2% gap
CITR
169.3%
-89.9%
VIR
Higher net margin
CITR
CITR
65224.2% more per $
CITR
-2751.2%
-67975.4%
VIR
More free cash flow
CITR
CITR
$166.4M more FCF
CITR
$-1.5M
$-167.9M
VIR
Faster 2-yr revenue CAGR
CITR
CITR
Annualised
CITR
218.8%
-88.0%
VIR

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
CITR
CITR
VIR
VIR
Revenue
$288.2K
$240.0K
Net Profit
$-7.9M
$-163.1M
Gross Margin
-99.7%
Operating Margin
-1470.3%
-72267.9%
Net Margin
-2751.2%
-67975.4%
Revenue YoY
169.3%
-89.9%
Net Profit YoY
-1110.1%
23.7%
EPS (diluted)
$-0.59
$-1.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CITR
CITR
VIR
VIR
Q3 25
$288.2K
$240.0K
Q2 25
$687.6K
$1.2M
Q1 25
$969.4K
$3.0M
Q4 24
$12.4M
Q3 24
$2.4M
Q2 24
$198.7K
$3.1M
Q1 24
$433.0K
$56.4M
Q4 23
$262.0K
$16.8M
Net Profit
CITR
CITR
VIR
VIR
Q3 25
$-7.9M
$-163.1M
Q2 25
$-11.9M
$-111.0M
Q1 25
$-10.9M
$-121.0M
Q4 24
Q3 24
$-213.7M
Q2 24
$-907.4K
$-138.4M
Q1 24
$-3.5M
$-65.3M
Q4 23
$-184.2K
Gross Margin
CITR
CITR
VIR
VIR
Q3 25
-99.7%
Q2 25
46.0%
99.1%
Q1 25
42.5%
Q4 24
Q3 24
97.9%
Q2 24
48.6%
98.3%
Q1 24
79.2%
99.9%
Q4 23
71.4%
95.2%
Operating Margin
CITR
CITR
VIR
VIR
Q3 25
-1470.3%
-72267.9%
Q2 25
-438.8%
-9754.3%
Q1 25
-356.8%
-4602.5%
Q4 24
Q3 24
-9718.7%
Q2 24
-456.7%
-5158.7%
Q1 24
-608.9%
-142.0%
Q4 23
-69.6%
Net Margin
CITR
CITR
VIR
VIR
Q3 25
-2751.2%
-67975.4%
Q2 25
-1731.1%
-9139.9%
Q1 25
-1124.8%
-3989.6%
Q4 24
Q3 24
-8979.7%
Q2 24
-456.7%
-4500.1%
Q1 24
-812.8%
-115.8%
Q4 23
-70.3%
EPS (diluted)
CITR
CITR
VIR
VIR
Q3 25
$-0.59
$-1.17
Q2 25
$-0.19
$-0.80
Q1 25
$-0.23
$-0.88
Q4 24
Q3 24
$-1.56
Q2 24
$-0.02
$-1.02
Q1 24
$-0.04
$-0.48
Q4 23
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CITR
CITR
VIR
VIR
Cash + ST InvestmentsLiquidity on hand
$497.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$8.5M
$796.1M
Total Assets
$12.3M
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CITR
CITR
VIR
VIR
Q3 25
$497.8M
Q2 25
$598.7M
Q1 25
$790.9M
Q4 24
$901.0M
Q3 24
$909.0M
Q2 24
$1.1B
Q1 24
$1.1B
Q4 23
$1.5B
Stockholders' Equity
CITR
CITR
VIR
VIR
Q3 25
$8.5M
$796.1M
Q2 25
$2.2M
$947.5M
Q1 25
$4.1M
$1.0B
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$3.2M
$1.4B
Q1 24
$3.8M
$1.5B
Q4 23
$1.6B
Total Assets
CITR
CITR
VIR
VIR
Q3 25
$12.3M
$1.0B
Q2 25
$8.7M
$1.2B
Q1 25
$9.1M
$1.3B
Q4 24
$1.4B
Q3 24
$1.5B
Q2 24
$5.4M
$1.7B
Q1 24
$5.3M
$1.8B
Q4 23
$5.3M
$1.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CITR
CITR
VIR
VIR
Operating Cash FlowLast quarter
$-1.5M
$-167.6M
Free Cash FlowOCF − Capex
$-1.5M
$-167.9M
FCF MarginFCF / Revenue
-525.6%
-69952.9%
Capex IntensityCapex / Revenue
18.7%
132.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-824.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CITR
CITR
VIR
VIR
Q3 25
$-1.5M
$-167.6M
Q2 25
$-1.2M
$-120.2M
Q1 25
$-713.9K
$-78.1M
Q4 24
$-446.4M
Q3 24
$-171.5M
Q2 24
$-424.9K
$-77.8M
Q1 24
$-343.7K
$-109.4M
Q4 23
$-391.8K
$-778.8M
Free Cash Flow
CITR
CITR
VIR
VIR
Q3 25
$-1.5M
$-167.9M
Q2 25
$-1.4M
$-122.8M
Q1 25
$-740.9K
$-79.7M
Q4 24
$-453.7M
Q3 24
$-174.2M
Q2 24
$-78.5M
Q1 24
$-111.3M
Q4 23
$-800.4M
FCF Margin
CITR
CITR
VIR
VIR
Q3 25
-525.6%
-69952.9%
Q2 25
-196.7%
-10111.8%
Q1 25
-76.4%
-2630.1%
Q4 24
-3666.2%
Q3 24
-7321.3%
Q2 24
-2553.3%
Q1 24
-197.4%
Q4 23
-4767.7%
Capex Intensity
CITR
CITR
VIR
VIR
Q3 25
18.7%
132.1%
Q2 25
20.5%
209.1%
Q1 25
2.8%
53.7%
Q4 24
59.0%
Q3 24
116.3%
Q2 24
0.0%
21.7%
Q1 24
0.0%
3.3%
Q4 23
128.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons